ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,353.60
-0.47%
S&P ASX All Technology
3,851.00
-0.79%
Brent Oil
73.405
2.04%
US Dollar vs AUD
1.57036
0.13%
Bitcoin
100,933.74
4.40%
Pepperstone
Advertisement
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Cytek Biosciences Inc (CTKB) Share Price

Cytek Biosciences Inc

Cytek Biosciences Inc (CTKB)

NASDAQ
6.68
-0.05
( -0.74% )
Updated: 06:16:23
Delayed by 15 minutes

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
6.68
Bid
6.68
Offer
6.69
Volume
146,187
6.455 Day's Range 6.77
4.66 52 Week Range 9.87
Market Cap
860.455M
Previous Close
6.73
Open
6.72
Last Trade
100
@
6.6824
(average)
Last Trade Time
06:16:29
Financial Volume
US$ 966,132
VWAP
6.6089
Average Volume (3m)
686,630
Shares Outstanding
128,810,614
Dividend Yield
-
PE Ratio
-70.73
Earnings Per Share (EPS)
-0.09
Revenue
193.02M
Net Profit
-12.15M

About Cytek Biosciences Inc

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-co... Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Show more

Sector
Lab Analytical Instruments
Industry
Lab Analytical Instruments
Website
www.cytekbio.com
Headquarters
Dover, Delaware, USA
Founded
-
Cytek Biosciences Inc is listed in the Lab Analytical Instruments sector of the NASDAQ with ticker CTKB. The last closing price for Cytek Biosciences was US$6.73. Over the last year, Cytek Biosciences shares have traded in a share price range of US$ 4.66 to US$ 9.87.

Cytek Biosciences currently has 128,810,614 shares in issue. The market capitalisation of Cytek Biosciences is US$866.90 million. Cytek Biosciences has a price to earnings ratio (PE ratio) of -70.73.

Ask ADVFN Intelligence (AI)

CTKB Latest News

More News

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

21 November 2024
Edgar (US Regulatory)

Cytek Biosciences to participate in the Piper Sandler 36th Annual Healthcare Conference

FREMONT, Calif., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced the company will be participating in the...

21 November 2024
GlobeNewswire Inc.

Cytek® Biosciences Named “Overall BioTech Company of the Year” in 2024 BioTech Breakthrough Awards Program

FREMONT, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) announced today that it has been named “Overall BioTech Company of the Year” in the fourth annual...

20 November 2024
GlobeNewswire Inc.

Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter

FREMONT, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB) has introduced an Enhanced Small Particle (ESP™) Detection Option for its Cytek Aurora™ CS system. This...

08 November 2024
GlobeNewswire Inc.

Form 8-K - Current report

06 November 2024
Edgar (US Regulatory)

Cytek Biosciences Reports Third Quarter 2024 Financial Results

FREMONT, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, today reported financial...

06 November 2024
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1006.686.896.4156068826.67295989CS
4-0.47-6.573426573437.157.155.686036776.50178743CS
121.3324.85981308415.357.634.666866306.00026888CS
260.7612.83783783785.927.634.666421255.85969951CS
52-0.98-12.79373368157.669.874.666833126.68172059CS
156-11.87-63.989218328818.5519.2453.88134219.27915212CS
260-13.42-66.766169154220.128.73.87517229.86076172CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
LAESSEALSQ Corporation
US$ 1.065
(86.51%)
197.58M
AMPGAmplitech Group Inc
US$ 1.7484
(76.23%)
169.89M
CADLCandel Therapeutics Inc
US$ 8.0501
(74.62%)
90.69M
LDTCLeddarTech Holdings Inc
US$ 1.8101
(49.60%)
68.34M
SFIXStitch Fix Inc
US$ 6.875
(49.46%)
22.04M
SFHGSamfine Creation Holdings Group Ltd
US$ 4.68
(-77.81%)
5.26M
CLRBCellectar Biosciences Inc
US$ 0.285772
(-77.67%)
32.86M
QTTBQ32 Bio Inc
US$ 6.53
(-73.25%)
1.93M
TFFPTFF Pharmaceuticals Inc
US$ 0.1791
(-40.75%)
2M
ANABAnaptysBio Inc
US$ 14.78
(-35.99%)
3.14M
RGTIRigetti Computing Inc
US$ 6.955
(7.16%)
258.12M
LAESSEALSQ Corporation
US$ 1.06
(85.64%)
199.54M
AMPGAmplitech Group Inc
US$ 1.75
(76.39%)
171.33M
NVDANVIDIA Corporation
US$ 139.42
(3.22%)
121.52M
CADLCandel Therapeutics Inc
US$ 8.08
(75.27%)
91.62M

Discussion

View Full Feed
DEMDOTS DEMDOTS 3 minutes ago
ok what be happening :o)
BURU
Jaxon2010 Jaxon2010 3 minutes ago
No pm. Trying to find out.
BURU
RIGATONI RIGATONI 3 minutes ago
How can they not know where they are originating from? Now it appears they do. Destroy the launch site which is apparently located on a ship EOM ~Rig
Paulie Pennies Paulie Pennies 3 minutes ago
$ASII Would love to see buybacks 😎
ASII
carvajal carvajal 4 minutes ago


HMBL
arachnodude arachnodude 4 minutes ago
You gotta cut some slack when one is used to others "paying to play" to get any sort of market traction.
KBLB
flipper44 flipper44 4 minutes ago
Continued: Pay attention!



A central conclusion from this study is that the means by which DCs are stimulated is a key determinant of vaccine efficacy. Data in support of this idea derive from our finding that adjuvants that induce DC activation (TLR ligands) or py
NWBO
carvajal carvajal 5 minutes ago
He has been doing it for at least 11 years, pretty sad tbh.
HMBL
jog49 jog49 5 minutes ago
"Will Trump push for plans to privatize Fannie Mae, Freddie Mac?"

Bigger question is does Trump even know much about the plight of F&F shareholders? My bet is he knows they are in conservatorships but none of the other details about how we were robbed by Obama, how we have been suppre
FNMA
novascotiaSTS novascotiaSTS 5 minutes ago
A number of these LIBOR settlements with have already been finalized with major banks without a single penny being awarded to the claimants. Of course facts won’t make a difference to those dreaming of hundreds of billions coming to former Escrow holders…
COOP
NinjaVolcano44 NinjaVolcano44 5 minutes ago
The numbers I had in mind after all the issuing shares, dilutions and convertible shares (4.1 million convertible to 41 million shares) are actually similar to those from chumfm. After the convertible are executed, Fusion will have around 63 million outstanding shares (current 18 million + 4 million
HTOO
rich2 rich2 5 minutes ago
On the breakout board, most read, most active always find NBRI there, many eyes upon NBRI

Just checked 6.8M buys verses 2M sells. Looking good in my opinion, especially for this time of year

in my opinion, SOON THIS LITTLE SPPEDBUMP WILL BE GONE
NBRI
uber darthium uber darthium 5 minutes ago
This was a scam, there was no product, there is no product, though researchers have delivered a new photocell that is more efficient, though still not efficient to meet the size requirement in order for this system to operate.

This concept will be a reality one day but this EGOMike fr
PMPG
XMaster2023 XMaster2023 5 minutes ago
Scotty, put your money in NVCR! Talk about a pump and dump. In concept, it is similar to an electric chair that you pay the company 20K per month to sit in 24/7/365 until you die.
ZERO chance of surviving 5 years. Prove me wrong!
NVCR
Lurker3 Lurker3 5 minutes ago
Not for any negative reason, but I will never again use the words "exciting" or "ubiquitous" when speaking about LightWave Logic Polymers in honour of Dr. Lebby's time with the company, those words are his alone,

Why did you write an eulogy. Did lebby die?

Relax man he
LWLG
Waalrus Waalrus 5 minutes ago
Geez. The games
AHRO
Alpha14 Alpha14 5 minutes ago
Because other market participants will use it as an opportunity to cover their years long short positions to profit on RNVAs massive decline in SP. Got to cover at some point to cash out. Everything else is just noise.
RNVA
weedtrader420 weedtrader420 5 minutes ago
XRP New Year’s 🥳 $4 TARGET
XRPUSD
i_like_bb_stock i_like_bb_stock 6 minutes ago
sure feels like it
AFFU
fuagf fuagf 6 minutes ago
OMOLIVES, It must be right up there, this is what i got -- Health Care Costs Number One Cause of Bankruptcy for American Families

Attorney Ed WoodsThe cost of health care is a major concern for nearly all Americans and there is no shortage of health care related news coverage recently
DiscoverGold DiscoverGold 6 minutes ago
How Low Historic Volatility Could Impact S&P 500 Performance
By: Schaeffer's Investment Research | December 11, 2024

• Low 20-day historical volatility and outperformance is bad combination for the SPX

• Extremely low volatility environments usually spell
Power of Emouna Power of Emouna 6 minutes ago
Yes exactly my thoughts! Go $PSRU
PSRU
fung_derf fung_derf 6 minutes ago
Me neither! And I agree with you. These egos are out of control!
We all should just listen to what you have to say.

BTW, why do you think John just vanished on you? Think he knew something?
P.S. the stock was around 8 cents when you made this post....

priv
GDVM
Jimmy Joe Jimmy Joe 6 minutes ago
Yeah, right right...........

Shareholders know the real reason, but thanks for the spin. Entertaining.

Howling at the moon.

🤣😸😅😸😆😸😂😹😂
DBMM
Power of Emouna Power of Emouna 7 minutes ago
I agree! $PSRU
PSRU

Your Recent History

NASDAQ
CTKB
Cytek Biosciences
BIT
P1GQI7
BNP Paribas Issuance
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved